https://www.selleckchem.com/products/a-769662.html
However, few individuals were reclassified to a high-risk threshold, resulting in negligible improvements in number needed to screen to prevent 1 event. In conclusion, incorporating statin effects from trial results into risk-prediction models enables statin-naive CVD risk estimation and provides moderate gains in predictive ability but had a limited impact on treatment decision-making under current guidelines in this population.Clinical prediction models (CPMs) are often used to guide treatment initiation, with individuals at high ris
Like
Comment
Share
